Delivery Order SPE2DB22D9207-SPE2DB25FH5BB
- Not listed
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract is a firm fixed-price delivery order with a ceiling value of $12,553.15 and an ultimate completion date of August 4, 2025. This award was made without a set-aside designation, and the place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $10,550.54 firm fixed-price delivery order on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of EXPAREL 133 mg/10 ml vials. The award carries an ultimate completion date of June 3, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for EXPAREL 266 mg/20 ml vials valued at $10,042.52. This firm fixed-price delivery order, which has a completion date of September 18, 2025, was issued without a set-aside designation. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,071.40 for EXPAREL 266 mg/20 ml vials. The contract, awarded on July 14, 2025, with an ultimate completion date of August 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $17,574.41 to DMS Pharmaceutical Group Inc. on August 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of September 2, 2025. This delivery order was issued without a set-aside designation, allowing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at approximately $25.1K for EXPAREL 266 mg/20 mL vials. This award was issued as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its small business status. EXPAREL is...
- The Defense Logistics Agency awarded a delivery order valued at $125,531.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This firm fixed-price delivery order, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, represents a direct procurement with no set-aside designation. The award falls under DMS Pharmaceutical Group's...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB25FH5BBDelivery Order
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $15,063.78 for EXPAREL 266 mg/20 ml vials. The award, issued on June 18, 2025, with an ultimate completion date of July 11, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program, a $500 million single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and infiltration during surgical procedures. This delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. The company's consistent success in securing pharmaceutical delivery orders through DLA demonstrates its capability to meet the specialized procurement requirements of military medical facilities across the nation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 6/18/25 |